PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0023418|leukemia |
| Sentences | 23 |
| PubMedID- 23683432 | [clinical study of allogeneic hematopoietic stem cell transplantation for patients with leukemia failing to achieve remission with chemotherapy]. |
| PubMedID- 25550955 | Background: we performed a systematic review and meta-analysis to compare the clinical outcomes and toxicity of reduced-intensity conditioning (ric) and myeloablative conditioning (mac) allogeneic hematopoietic stem cell transplantation (allohsct) in patients with acute myeloid leukemia (aml) and myelodysplastic syndrome (mds). |
| PubMedID- 25262825 | hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and down syndrome. |
| PubMedID- 19961944 | Natural killer (nk) cell alloreactivity, which may contribute to the graft-versus-leukemia (gvl) effect of allogeneic hematopoietic stem cell transplantation (hsct), is influenced by the interaction of killer-cell immunoglobulin-like receptors (kirs) on donor nk cells and their ligands, human leukocyte antigen (hla) class i molecules on recipient antigen-presenting cells (apcs). |
| PubMedID- 21421478 | Objective: to analyze the influence of hla compatibility on the outcome of allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with chronic myeloid leukemia (cml). |
| PubMedID- 22737613 | Our study suggests that the reconstitution of the peripheral inkt cell compartment, following hla-haploidentical hematopoietic stem cell transplantation, associates with leukemia control in children affected by different hematological malignancies. |
| PubMedID- 26183077 | Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with acute myeloid leukemia (aml) and myelodysplastic syndromes (mds) represents a promising tool for predicting disease relapse, although its precise role in this setting remains unclear. |
| PubMedID- 25687068 | [analysis of prognosis in acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 22089346 | In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor dna on the basis of str loci showing copy number alteration. |
| PubMedID- 26422713 | Cd25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplantation predicts relapse in patients with acute myeloid leukemia without complete remission. |
| PubMedID- 22652755 | The graft-versus-leukemia effect of allogeneic hematopoietic stem cell transplantation (hsct) has shown that the immune system is capable of eradicating acute myeloid leukemia (aml). |
| PubMedID- 25130828 | This study was purposed to explore the therapeutic efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with chronic myelomonocytic leukemia (cmml) and in patients with juvenile myelomonocytic leukemia (jmml). |
| PubMedID- 24060407 | Comparison of unrelated cord blood transplantation and hla-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage. |
| PubMedID- 24417923 | [treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase]. |
| PubMedID- 22428765 | Abnormal cardiomarkers in leukemia patients treated with allogeneic hematopoietic stem cell transplantation. |
| PubMedID- 22245568 | Polymorphisms of the cytotoxic t-lymphocyte antigen-4 gene (ctla-4) have been associated with autoimmune diseases and it has recently been reported that donor genotypes correlate with the outcome of allogeneic hematopoietic stem cell transplantation in leukemia patients. |
| PubMedID- 25072307 | Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis. |
| PubMedID- 24767158 | [clinical outcome of flt3-itd (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 24137943 | Aim: to evaluate the efficiency of allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with acute myeloblastic leukemia in first remission depending on the regimens of conditioning, the source of a graft, and the characteristics of a donor and a recipient. |
| PubMedID- 26095886 | Several lines of evidence, including the graft versus leukemia effect associated with allogeneic hematopoietic stem cell transplantation (hsct), suggest that immunotherapy is an active modality in aml. |
| PubMedID- 23134857 | Conclusions: early lymphocyte count (lc30) post-allogeneic hematopoietic stem cell transplantation in leukemia is highly associated with prognosis, which can be the independent prognosis index after allo-hsct in leukemia and can identify a group of patients who might be suitable candidates for early interventions treatment. |
| PubMedID- 23396805 | Allogeneic nk cells exhibit potent anti-tumor activities that are beneficial in the setting of hematopoietic stem cell transplantation into patients with acute myeloid leukemia (9). |
| PubMedID- 21252092 | Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. |
Page: 1